This study is being carried out in 4 countries (France, Italy, Spain and the UK) to understand the clinical care pathway of population living with type 2 diabetes who also have evidence of chronic kidney disease. The primary objective is to describe the population with T2D and CKD in terms of demography, clinical characteristics and medication use by CKD stage.
Study Type
OBSERVATIONAL
Enrollment
110,074
No treatment given
Novo Nordisk Investigational site
Bangalore, India
Prevalence of various CKD stages among patients with type 2 diabetes in the THIN database
* Distribution of CKD stages, as determined by eGFR, in patients with and w/out CKD diagnosis * (+/- ACD-10 code for CKD) in cohort of patients diagnosed with T2D.
Time frame: From the registration date to 1 January 2021
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.